Portalvein reconstruction with a cadaveric descending thoracic aortic homograft.
Improvements in chemoradiotherapy have rendered complex pancreatic cancers involving the portal vein (PV) amenable to resection. PV reconstruction (PVR) is an essential component. Various conduits have been proposed; however, the optimal choice remains unknown. Fourteen patients underwent PVR with a cadaveric descending thoracic aortic homograft from 2014 to 2020. The primary diagnosis was pancreatic cancer. The splenic vein was ligated in seven patients (50%). The 30-day and 3-, 12-, and 24-month primary patency rates were 100%, 86%, 76%, and 76%, respectively. We found a cadaveric descending thoracic aortic homograft is an excellent conduit for PVR, given the optimal size, rapidly availability, favorable risk profile, and absence of harvest site complications.
Published In/Presented At
Gaffey, A. C., Zhang, J., Lee, M. K., Roses, R., Jackson, B. M., & Quatromoni, J. G. (2022). Portalvein reconstruction with a cadaveric descending thoracic aortic homograft. Journal of vascular surgery cases and innovative techniques, 8(2), 294–297. https://doi.org/10.1016/j.jvscit.2022.04.001
Medicine and Health Sciences
Department of Medicine, Cardiology Division